Also, we found that Gal-3 gene expression levels in T2DM with CAD patients were significantly higher than the additional two groups, and the genotypes C allele carrier (AC+CC, n=220) had associated LGALS-3 mRNA expression significantly higher than the A allele carrier (AA). The gene discussed is LGALS3; the disease is type 2 diabetes mellitus.